Literature DB >> 27882172

Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.

Yunfeng Yi1, Xiujuan Lu1, Jianming Chen1, Changjie Jiao1, Jing Zhong1, Zhiming Song1, Xiaoping Yu1, Baoli Lin1.   

Abstract

microRNAs (miRNAs/miRs) are crucial regulators of gene expression at the post-translational level through promoting mRNA degradation or the repression of translation of target genes. miRs have been confirmed to serve a dominant role in tumor biology. miR-486-5p has been ascertained to be involved in non-small-cell lung cancer, breast cancer and hepatocellular carcinoma; however, the expression and function of miR-486-5p in esophageal squamous cell carcinoma (ESCC) has yet to be elucidated. The present study aimed to analyze the expression levels of miR-486-5p in ESCC tissues and paired normal adjacent tissues, and determine the effects of miR-486-5p on esophageal cancer cells using MTT, wound scratch and apoptosis assays. The current results showed that miR-486-5p was significantly downregulated in ESCC specimens. Ectopic expression of miR-486-5p by synthetic mimics reduced cell proliferation and migration and induced increased cell apoptosis. The results indicated miR-486-5p may function as a tumor suppressor in ESCC. The present study demonstrated that miR-486-5p was downregulated in ESCC and served a anti-oncogene role in ESCC via affecting cellular migration.

Entities:  

Keywords:  downregulated; esophageal squamous cell carcinoma; miR-486-5p; tumor suppressor

Year:  2016        PMID: 27882172      PMCID: PMC5103827          DOI: 10.3892/etm.2016.3783

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8.

Authors:  Sharmistha Bhattacharyya; Nagaraja S Balakathiresan; Clifton Dalgard; Usha Gutti; David Armistead; Cathy Jozwik; Meera Srivastava; Harvey B Pollard; Roopa Biswas
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

3.  MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).

Authors:  Soken Tsuchiya; Takeshi Fujiwara; Fumiaki Sato; Yutaka Shimada; Eiji Tanaka; Yoshiharu Sakai; Kazuharu Shimizu; Gozoh Tsujimoto
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

4.  The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

Authors:  Liu Hong; Yu Han; Hongwei Zhang; Mengbin Li; Taiqian Gong; Li Sun; Kaichun Wu; Qingchuan Zhao; Daiming Fan
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

5.  Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

Authors:  Hajime Shibuya; Hisae Iinuma; Ryu Shimada; Atsushi Horiuchi; Toshiaki Watanabe
Journal:  Oncology       Date:  2011-03-17       Impact factor: 2.935

Review 6.  MicroRNAs and esophageal squamous cell carcinoma.

Authors:  Kayoko Matsushima; Hajime Isomoto; Shigeru Kohno; Kazuhiko Nakao
Journal:  Digestion       Date:  2010-06-25       Impact factor: 3.216

7.  Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.

Authors:  Marco Ragusa; Alessandra Majorana; Luisa Statello; Marco Maugeri; Loredana Salito; Davide Barbagallo; Maria Rosa Guglielmino; Laura R Duro; Rosario Angelica; Rosario Caltabiano; Antonio Biondi; Maria Di Vita; Giuseppe Privitera; Marina Scalia; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Francesco Basile; Cinzia Di Pietro; Michele Purrello
Journal:  Mol Cancer Ther       Date:  2010-09-29       Impact factor: 6.261

8.  Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Dorothee Wernicke; Hansjuerg Alder; Stefan Costinean; Stefano Volinia; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

9.  MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.

Authors:  Xiqiang Liu; Jinsheng Yu; Lu Jiang; Anxun Wang; Fei Shi; Hui Ye; Xiaofeng Zhou
Journal:  Cancer Genomics Proteomics       Date:  2009 May-Jun       Impact factor: 4.069

10.  MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.

Authors:  Yin Xiong; Lisa Zhang; Alisha K Holloway; Xiaolin Wu; Ling Su; Electron Kebebew
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

View more
  21 in total

1.  MicroRNA-486-5p suppresses TGF-β2-induced proliferation, invasion and epithelial-mesenchymal transition of lens epithelial cells by targeting Smad2.

Authors:  Bei Liu; Jianhua Sun; Xiaoqin Lei; Zhongqiao Zhu; Cheng Pei; Li Qin
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

2.  Prognostic value of microRNA-378 in esophageal cancer and its regulatory effect on tumor progression.

Authors:  Wei Jin; Lixin Wang; Sujie Cheng; Hongmei Lv
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

3.  MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung adenocarcinoma cells.

Authors:  Desheng Wei
Journal:  Histol Histopathol       Date:  2022-04-25       Impact factor: 2.130

4.  miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma.

Authors:  Jie Feng; Bo Qi; Ling Guo; Ling-Yun Chen; Xiu-Feng Wei; Yu-Zhen Liu; Bao-Sheng Zhao
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

5.  MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xianglin Yang; Chang Zheng; Xia Hao; Ruoyi Qu; Baosen Zhou
Journal:  Oncotarget       Date:  2018-01-12

6.  Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.

Authors:  Xiangxiang Liu; Tao Xu; Xiuxiu Hu; XiaoXiang Chen; Kaixuan Zeng; Li Sun; Shukui Wang
Journal:  Cancer Manag Res       Date:  2018-04-24       Impact factor: 3.989

7.  Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis.

Authors:  Xiaohua Chen; Sina Cai; Baoxia Li; Xiaona Zhang; Wenhui Li; Henglun Linag; Xiaolong Cao
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

8.  Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.

Authors:  Qian Yang; Wen-Wen Gu; Yan Gu; Na-Na Yan; Yan-Yan Mao; Xing-Xing Zhen; Jian-Mei Wang; Jing Yang; Hui-Juan Shi; Xuan Zhang; Jian Wang
Journal:  J Transl Med       Date:  2018-07-04       Impact factor: 5.531

9.  miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer.

Authors:  Sunfeng Yu; Shuang Geng; Yi Hu
Journal:  Oncol Lett       Date:  2018-06-29       Impact factor: 2.967

10.  miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.

Authors:  Baoping Lang; Song Zhao
Journal:  Oncol Rep       Date:  2017-11-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.